Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans L Spiegelberg

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Opinion in Molecular Therapeutics|March 9, 2002
DNA-based approaches to the treatment of allergiesHans L Spiegelberg, Eyal Raz
Expert Review of Vaccines|August 7, 2003
DNA-based vaccines for allergic diseaseHans L Spiegelberg, Kenji Takabayashi, Lucinda Beck, et al.
Current Opinion in Allergy and Clinical Immunology|January 31, 2004
Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapyHans L Spiegelberg, Anthony A Horner, Kenji Takabayashi, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2002
Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicityAnthony A Horner, Kenji Takabayashi, Lucinda Beck, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Opinion in Molecular Therapeutics|March 9, 2002
DNA-based approaches to the treatment of allergiesHans L Spiegelberg, Eyal Raz
Expert Review of Vaccines|August 7, 2003
DNA-based vaccines for allergic diseaseHans L Spiegelberg, Kenji Takabayashi, Lucinda Beck, et al.
Current Opinion in Allergy and Clinical Immunology|January 31, 2004
Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapyHans L Spiegelberg, Anthony A Horner, Kenji Takabayashi, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2002
Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicityAnthony A Horner, Kenji Takabayashi, Lucinda Beck, et al.
Pageof 1